Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Title Analyst Sarah James Reaffirms Underweight Rating for Universal Health Services

Elaine Mendonca by Elaine Mendonca
March 5, 2024
in Breaking News
0
Finance_Financing
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On March 5, 2024, Sarah James, an analyst at Cantor Fitzgerald, restated her assessment of Universal Health Services (NYSE: UHS) with a rating of Underweight and a price target of $156. This reaffirmation reflects James’ view on how the stock is expected to fare compared to others in its industry. ___

Universal Health Services (UHS) Stock Shows Strength with Positive Trading Day on March 5, 2024

On March 5, 2024, Universal Health Services (UHS) experienced a positive trading day as its stock price showed signs of strength. UHS is currently trading near the top of its 52-week range and above its 200-day simple moving average, indicating a bullish trend. The price of UHS shares increased by $0.51 on March 5, representing a 0.29% rise from the previous trading day. Despite opening lower at $173.73, UHS managed to recover and end with a positive gain. Investors may have been encouraged by UHS’s strong performance on March 5, especially considering the challenges faced by the healthcare sector. It is important for investors to continue monitoring UHS’s stock performance to see if the positive momentum can be sustained. Overall, UHS’s stock performance on March 5, 2024, was a bright spot in an otherwise turbulent market, indicating potential future growth and success in the healthcare sector.

Universal Health Services (UHS) Stock Shows Promising Performances: Financial Analysis and Outlook

On March 5, 2024, Universal Health Services (UHS) stock showed promising performances based on the financial data provided by CNN Money. The company reported a total revenue of $14.28 billion for the past year, with a quarterly revenue of $3.70 billion. In terms of net income, UHS reported a net income of $717.49 million for the past year, with a quarterly net income of $216.31 million. Furthermore, the earnings per share (EPS) for UHS were reported at $10.23 for the past year and $3.16 for the last quarter. Overall, these financial indicators suggest that UHS has been performing well in terms of revenue, net income, and earnings per share. The consistent growth in revenue and net income over the past year reflects positively on the company’s financial health and stability. Additionally, the increase in EPS indicates that UHS is generating more profits for its shareholders. Investors and analysts may view these positive financial performances as a good sign for UHS stock. However, it is essential to conduct further research and analysis before making any investment decisions based on this information.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Financing

Stifel Analyst Nathan Jones Reaffirms Buy Rating for Parker Hannifin

Tech-Innovations

Addressing the Chip Engineer Shortage in Japan PSMCs Innovative Initiative

Entertainment Markets and money

Revitalizing Marvel Bob Igers Commitment to Excellence

Recommended

The Trade Desk Stock

The Trade Desk: Market Contrarians See Opportunity in Plunge

2 months ago
Kraft Heinz Stock

Kraft Heinz Split Draws Rare Public Rebuke from Frustrated Buffett

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Face Sustained Selling Pressure

5 months ago
Diginex Stock

Diginex Shares Under Pressure as Investor Confidence Wanes

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

Trending

Exxon Mobil Stock
Analysis

Exxon Mobil Charts a New Course with Major Carbon Capture Initiative

by Andreas Sommer
February 5, 2026
0

Exxon Mobil is accelerating its strategic pivot, bolstering its portfolio with significant investments in low-carbon energy solutions....

CrowdStrike Stock

CrowdStrike Shares Face Headwinds Amid Mixed Signals

February 5, 2026
NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Exxon Mobil Charts a New Course with Major Carbon Capture Initiative
  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com